Description
A KDM4B/JMJD2B inhibitor (IC50 = ~10 nM); selective for KDM4B/JMJD2B over KDM5A/JARID1 and LSD1 but does inhibit KDM4A/JMJD2A, KDM4C/JMJD2C, and KDM4D/JMJD2D at 10 μM; inhibits the growth of various prostate cancer cells (IC50s = <1 μM for all); reduces androgen receptor levels and H3K9 trimethylation in isolated human solid prostate tumors; reduces tumor volume in a PC3 mouse xenograft model at 20 mg/kg
Formal name: 3-(8-hydroxy-6-quinolinyl)-N-(3-phenylpropyl)-benzamide
Synonyms:
Molecular weight: 382.5
CAS: 2003260-55-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Demethylases||Research Area|Epigenetics, Transcription, & Translation|Erasers